Co-Authors
This is a "connection" page, showing publications co-authored by Massimo Filippi and Paolo Preziosa.
Connection Strength
1.918
-
COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience. J Neurol. 2021 Aug; 268(8):2697-2699.
Score: 0.914
-
COVID-19 will change MS care forever - No. Mult Scler. 2020 09; 26(10):1149-1151.
Score: 0.888
-
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives. J Neurol. 2022 Mar; 269(3):1316-1334.
Score: 0.060
-
COVID-19 in teriflunomide-treated patients with multiple sclerosis. J Neurol. 2020 Oct; 267(10):2790-2796.
Score: 0.055